Driving Simulation Cross-Over Study of Sedative Effects of Tolperisone Compared to Cyclobenzaprine and Placebo

Trial Profile

Driving Simulation Cross-Over Study of Sedative Effects of Tolperisone Compared to Cyclobenzaprine and Placebo

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Dec 2017

At a glance

  • Drugs Tolperisone (Primary) ; Cyclobenzaprine
  • Indications Muscle hypertonia; Muscle spasticity; Spasm
  • Focus Therapeutic Use
  • Sponsors Neurana Pharmaceuticals
  • Most Recent Events

    • 21 Nov 2017 Status changed from recruiting to active, no longer recruiting.
    • 26 Oct 2017 Primary endpoint (Standard Deviation of Lateral Position (SDLP)) has been met according to a Neurana Pharmaceuticals media release.
    • 26 Oct 2017 Top-line results presented in a Neurana Pharmaceuticals media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top